That authors concluded that use of older stored blood for transfusion was associated with a significantly increased risk of death. This conclusion reflects the evidence presented but clinical and methodological differences between the studies and the possibility of missed relevant studies mean that the reliability of this conclusion is undecided.
Assessment of study quality
The authors did not report any quality assessment.
Data extraction
Two reviewers independently extracted data (count data, adjusted hazard ratios or risk ratios) to calculate odds ratios with 95% confidence intervals for mortality or severe adverse events with transfusion of older versus newer blood. Where studies had multiple methods for division, the method that provided the greatest age gap between old and new stored blood was used. Where more than one cut-off value was used to divide the two stored blood groups, the cutoff closest to 21 days was used. For studies that compared each transfused group with a third group, the comparison of oldest versus newest blood was calculated. Where the estimated effect was based on a continuous blood age, the estimated effect size of third-quartile blood age was compared with first-quartile blood age. Adverse events were reported if they were significant and combined, where appropriate, when they were reported in at least two studies.
Any discrepancies in data extraction were resolved by a third reviewer.
Methods of synthesis
Odds ratios and 95% confidence intervals were pooled using a random-effects model. Heterogeneity was assessed using Q and Ι² statistics (Ι²≤30% indicated low heterogeneity). Subgroup analyses were performed according to study population (subgroups of primary diagnosis types, adults and paediatric patients) and severe adverse events. Publication bias was assessed using a funnel plot and Egger's regression test. Overall mortality estimates for count data versus adjusted results from the same studies were compared using the exact Wilcoxon matched-pairs signed-rank test.
